Histone deacetylases inhibitors (HDACis) as novel therapeutic application in various clinical diseases

被引：68

作者：

Qiu, Xiaoyan ^{[1
]}

Xiao, Xiong ^{[1
]}

Li, Nan ^{[1
]}

Li, Yuemin ^{[1
]}

机构：

[1] Southwest Univ, Sch Anim Sci & Technol, 2 Tian Sheng St, Chongqing 400715, Peoples R China

来源：

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 2017年 / 72卷

基金：

中国国家自然科学基金;

关键词：

HDACi; Brain disorders; Cancer; Endometriosis; Cell reprogramming; SUBEROYLANILIDE HYDROXAMIC ACID; SPINAL MUSCULAR-ATROPHY; CELL NUCLEAR TRANSFER; RUBINSTEIN-TAYBI-SYNDROME; IN-VITRO DEVELOPMENT; EXPERIMENTALLY-INDUCED ENDOMETRIOSIS; TRANSGENIC MOUSE MODEL; LONG-TERM-MEMORY; PHASE-II TRIAL; PROTECTS DOPAMINERGIC-NEURONS;

D O I：

10.1016/j.pnpbp.2016.09.002

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Accumulating evidence suggests that histone hypoacetylation which is partly mediated by histone deacetylase (HDAC), plays a causative role in the etiology of various clinical disorders such as cancer and central nervous diseases. HDAC inhibitors (HDACis) are natural or synthetic small molecules that can inhibit the activities of HDACs and restore or increase the level of histone acetylation, thus may represent the potential approach to treating a number of clinical disorders. This manuscript reviewed the progress of the most recent experimental application of HDACis as novel potential drugs or agents in a large number of clinical disorders including various brain disorders including neurodegenerative and neurodevelopmental cognitive disorders and psychiatric diseases like depression, anxiety, fear and schizophrenia, and cancer, endometriosis and cell reprogramming in somatic cell nuclear transfer in human and animal models of disease, and concluded that HDACis as potential novel therapeutic agents could be used alone or in adjunct to other pharmacological agents in various clinical diseases. (C) 2016 Elsevier Inc. All rights reserved.

引用

页码：60 / 72

页数：13

共 283 条

[1] Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders [J].

Abe, Ted ;

Zukin, R. Suzanne .

CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (01) :57-64

[2] Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice:: A model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration [J].

Alarcón, JM ;

Malleret, G ;

Touzani, K ;

Vronskaya, S ;

Ishii, S ;

Kandel, ER ;

Barco, A .

NEURON, 2004, 42 (06) :947-959

[3] Phenylbutyrate increases SMN expression in vitro:: relevance for treatment of spinal muscular atrophy [J].

Andreassi, C ;

Angelozzi, C ;

Tiziano, FD ;

Vitali, T ;

De Vincenzi, E ;

Boninsegna, A ;

Villanova, M ;

Bertini, E ;

Pini, A ;

Neri, G ;

Brahe, C .

EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (01) :59-65

[4] Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy [J].

Avila, Amy M. ;

Burnett, Barrington G. ;

Taye, Addis A. ;

Gabanella, Francesca ;

Knight, Melanie A. ;

Hartenstein, Parvana ;

Cizman, Ziga ;

Di Prospero, Nicholas A. ;

Pellizzoni, Livio ;

Fischbeck, Kenneth H. ;

Sumner, Charlotte J. .

JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) :659-671

[5] Genetic heterogeneity in Rubinstein-Taybi syndrome:: delineation of the phenotype of the first patients carrying mutations in EP300 [J].

Bartholdi, Deborah ;

Roelfsema, Jeroen H. ;

Papadia, Francesco ;

Breuning, Martijn H. ;

Niedrist, Dunja ;

Hennekam, Raoul C. ;

Schinzel, Albert ;

Peters, Dorien J. M. .

JOURNAL OF MEDICAL GENETICS, 2007, 44 (05) :327-333

[6]

Bartolini G, 2008, ANTICANCER RES, V28, P283

[7] Differential contributions of Caenorhabditis elegans histone deacetylases to Huntingtin polyglutamine toxicity [J].

Bates, EA ;

Victor, M ;

Jones, AK ;

Shi, Y ;

Hart, AC .

JOURNAL OF NEUROSCIENCE, 2006, 26 (10) :2830-2838

[8] Huntington's disease - Exploiting expression [J].

Bates, GP .

NATURE, 2001, 413 (6857) :691-+

[9] Cytochalasin B and Trichostatin A Treatment Postactivation Improves In Vitro Development of Porcine Somatic Cell Nuclear Transfer Embryos [J].

Beebe, Luke F. S. ;

Mcllfatrick, Stephen J. ;

Nottle, Mark B. .

CLONING AND STEM CELLS, 2009, 11 (04) :477-482

[10] SIRT1 inhibition alleviates gene silencing in fragile X mental retardation syndrome [J].

Biacsi, Rea ;

Kumari, Daman ;

Usdin, Karen .

PLOS GENETICS, 2008, 4 (03)

← 1 2 3 4 5 6 7 8 9 10 →